We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AS

News List

Novartis, Cadila Healthcare lead digital marketing space for ankylosing spondylitis in India: GlobalData expresspharma
May 21, 2021
Novartis and Cadila Healthcare are the only companies to offer support to AS patients through digital channels, finds GlobalData.
AbbVie's Rinvoq bags two new EU approvals pharmatimes
January 27, 2021
The European Commission (EC) has approved AbbVie’s Rinvoq (upadacitinib) for the treatment of active psoriatic arthritis (PsA) and active ankylosing spondylitis (AS).
Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA drugs
August 29, 2019
In a special article published online in Arthritis Care & Research, the American College of Rheumatology, Spondylitis Association of America...
Novartis’ Scapho shows pioneering 4-year data in preventing Ankylosing Spondylitis progression expressbpd
December 13, 2017
These new data also confirm sustained improvement in signs and symptoms in almost 80 percent of patients, with a favourable and consistent safety profile